The global market for point-of-care molecular diagnostics is anticipated to expand at a CAGR of 8.5% during the forecast period of 2023 and 2031. The rise of the point-of-care molecular diagnostics market is primarily driven by the increasing prevalence of infectious diseases and cancer, as well as the growing desire of end users for point-of-care molecular testing due to its attractive features. Medical personnel has long utilized molecular diagnostics in laboratories and other healthcare settings. However, the expensive cost of testing, the time-consuming nature, and the delayed findings of molecular diagnostics has encouraged them to seek out alternative diagnostic methods. This has brought the market for molecular diagnostics at the point of care into the limelight. Point-of-care molecular diagnostics has acquired significant traction across end-use verticals, including hospitals and research institutes, due to its ability to cut turnaround time and deliver reliable results quickly. Molecular testing at the point of care enables the rapid and early diagnosis of illnesses in non-laboratory settings. Typically, these tests are administered at the locations of close patients.
A key factor driving the growth of the point-of-care molecular diagnostics market is the increasing adoption of point-of-care molecular diagnostic solutions for the early detection of a wide range of diseases, from respiratory diseases and cancer to sexually transmitted diseases and gastrointestinal disorders. In the future years, the rapid expansion of the molecular diagnostics and molecular imaging markets, fueled by rising health consciousness in emerging nations, will generate possibilities for point-of-care molecular diagnostics producers. In addition, recent advances in microfluidics and genetic sequencing, along with the development of low-cost and speedy point-of-care molecular diagnostic platforms, will increase sales of POC molecular diagnostics devices, thereby growing market for molecular POC tests.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
A key factor driving the growth of the point-of-care molecular diagnostics market is the increasing adoption of point-of-care molecular diagnostic solutions for the early detection of a wide range of diseases, from respiratory diseases and cancer to sexually transmitted diseases and gastrointestinal disorders. In the future years, the rapid expansion of the molecular diagnostics and molecular imaging markets, fueled by rising health consciousness in emerging nations, will generate possibilities for point-of-care molecular diagnostics producers. In addition, recent advances in microfluidics and genetic sequencing, along with the development of low-cost and speedy point-of-care molecular diagnostic platforms, will increase sales of POC molecular diagnostics devices, thereby growing market for molecular POC tests.
Rising Frequency of Infectious and Malignant Diseases
The rising incidence of infectious diseases and cancer in both developed and emerging regions will favorably impact the growth of the market for point-of-care molecular diagnostics. The increasing frequency of prescriptions for molecular diagnostic tests is attributable to the diagnosis and treatment of such disorders. Demand for point-of-care molecular diagnostics is anticipated to be driven over the projected period by the aforementioned causes and the growing trend toward preventive medicine.Opportunities For Expansion in Emerging Nations
Emerging economies such as India, South Korea, Brazil, and Mexico present substantial growth potential to market participants in the point-of-care molecular diagnostics sector. This is due to low regulatory hurdles, advancements in healthcare infrastructure, a growing patient population, an increase in the prevalence of infectious diseases, and rising healthcare expenditures. In addition, the regulatory policies of several of these nations are more adaptable and business-friendly than those of developed nations.Unfavorable Reimbursement Scenario to Limit the Market Growth
Inadequate reimbursements are a major factor inhibiting the growth of the market for molecular diagnostics at the point of care. Getting Medicare and private health insurers to pay for diagnostic testing is a significant obstacle to the commercialization of most diagnostic tests. In 2018, Medicare in the United States updated its funding process for several IVD tests, including point-of-care molecular diagnostics. Several of these tests are billed using unlisted Healthcare Common Procedure Coding System (HCPCS) codes. In such instances, Medicare Administrative Contractors (MACs) establish a payment amount for their respective local governments. CMS cut the Medicare payment rate for COVID-19 tests based on high throughput technology to USD 75 unless laboratories can process findings in less than two days. Medicare does not currently fund genetic testing for those without a cancer family history (Source: American Society of Clinical Oncology).Infectious Diseases Led the Market by Application
PoC testing in molecular diagnostics has many uses, including testing near the patient in infectious disease management, oncology, hematology, prenatal screening, and endocrinology. In the disciplines of infectious illnesses and oncology, point-of-care (PoC) molecular testing has seen the greatest application-based advancements. In 2022, the infectious diseases segment had the biggest revenue share. Contributing to the revenue share of infectious diseases for rapid molecular diagnostic tests are the provision and facilitation of appropriate antibiotic therapy, faster disease management, enhanced distribution of healthcare laboratory assets, and reductions in mortality and healthcare expenditures.PCR Based Testing Led the Market by Technology
On the basis of technology, the market for point-of-care molecular diagnostics has been divided into PCR-based, genetic sequencing-based, hybridization-based, and microarray-based tests and devices. In 2022, PCR-based testing generated the greatest revenue share. The market will be driven by the commercialization of point-of-care diagnostics that deliver accurate, rapid real-time PCR analysis for infectious illnesses such as H1N1 and influenza. Due to a number of industry advances, NGS-based molecular testing in close proximity to the patient is expected to have substantial growth during the projection period. Innovative platform modifications that enable genetic sequencing and DNA data processing at the point of care with high precision and give speedy diagnosis contribute to the predicted growth of this market sector. Rapid DNA analysis is anticipated to have substantial growth in the next years as a result of the continuing innovation and R&D efforts of market leaders.OTC Tests to Dominate During the Forecast Period for Market by Test Site
The market is divided into Proof-of-Concept (PoC) and Over-the-Counter (OTC) tests, depending on the location of the tests. The versatility and portability of OTC tests are superior to POC tests for use in homes and assisted care facilities. The majority of OTC users are untrained professionals and, in the majority of cases, the patients themselves. In addition, a number of these testing instruments are exempt from CLIA, which encourages their use outside of laboratories. Over-the-counter (OTC) tests are anticipated to create more revenue during the projected period due to their usability, accessibility, and higher adoption rate.Decentralized Laboratories Led the Market by End User
The market is segmented by end-use into decentralized laboratories, hospitals, home care, and assisted living healthcare facilities, among others. In 2022, decentralized laboratories generated the greatest revenue share. The ability of these tests to provide speedy and accurate molecular analysis with a substantially smaller physical footprint than their central laboratory-based equivalents is a crucial driver in the segment's greater revenue share.APAC to Remain the Fastest-Growing Region
Continuous efforts by big market participants to bolster their market position are a significant contributor to the majority share. In addition, a number of clinical studies examining the efficacy and precision of novel molecular tests are anticipated to contribute to the expansion of the market throughout the forecast period. The growing need for speedy diagnosis and the introduction of innovative molecular diagnostic procedures for DNA analysis has positioned Europe as a significant market niche. Due to a lack of advanced central laboratory testing services, a bigger population base requiring clinical testing, and the potential cost-effective implementation of PoC molecular assays, Asia Pacific is predicted to experience the highest growth rate over the forecast period.Innovations Remain as the Key to Enhance Market Shares
Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMerieux S.A., Danaher Corporation, Quidel Corporation, QIAGEN N.V., Co-Diagnostics, Inc. Biocartis NV, Meridian Bioscience, Inc., Thermo Fisher Scientific, Inc., and other notable players. These firms are continually concentrating on the development of innovative point-of-care molecular diagnostic platforms, such as the point-of-care molecular COVID test and paper-based nucleic acid amplification assays, which may diagnose diseases with relative simplicity. In addition, they have utilized techniques such as mergers, acquisitions, and alliances, among others, to increase its global presence.Key developments:
- In March 2020, Abbott Laboratories will release the ID NOW point-of-care test for coronavirus detection.
- In July 2021, QuantuMDx introduced Q-POCTM, a fast PCR diagnostic technology for the point of care.
- Co-Diagnostics, a molecular diagnostics company, successfully acquired Idaho Molecular and Advanced Conceptions in 2022.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Point of Care Molecular Diagnostics market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Point of Care Molecular Diagnostics market and their expected impact during the forecast period.
Market Segmentation Product & Service
- Assays & kits
- Instruments &Analyzers
- Software & Services
Technology
- RT-PCR
- INAAT
- Other technologies
Application
- Respiratory Diseases
- Sexually Transmitted Diseases
- Hospital-acquired Infections
- Cancer
- Hepatitis
- Gastrointestinal Disorders
- Other Applications
End User
- Physicians’ Offices
- Hospitals & ICUs
- Research Institutes
- Other End Users
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Point of Care Molecular Diagnostics market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Point of Care Molecular Diagnostics market?
- Which is the largest regional market for Point of Care Molecular Diagnostics market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Point of Care Molecular Diagnostics market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Point of Care Molecular Diagnostics market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Point of Care Molecular Diagnostics Market
2.2. Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022 (US$ Million)
2.3. Global Point of Care Molecular Diagnostics Market, By Technology, 2022 (US$ Million)
2.4. Global Point of Care Molecular Diagnostics Market, By Application, 2022 (US$ Million)
2.5. Global Point of Care Molecular Diagnostics Market, By End User, 2022 (US$ Million)
2.6. Global Point of Care Molecular Diagnostics Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022
3. Point of Care Molecular Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Point of Care Molecular Diagnostics Market Vendors
3.2. Strategies Adopted by Point of Care Molecular Diagnostics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Point of Care Molecular Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Point of Care Molecular Diagnostics Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Assays & kits
5.3.2. Instruments &Analyzers
5.3.3. Software & Services
6. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. RT-PCR
6.3.2. INAAT
6.3.3. Other technologies
7. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Respiratory Diseases
7.3.2. Sexually Transmitted Diseases
7.3.3. Hospital-acquired Infections
7.3.4. Cancer
7.3.5. Hepatitis
7.3.6. Gastrointestinal Disorders
7.3.7. Other Applications
8. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Physicians’ Offices
8.3.2. Hospitals & ICUs
8.3.3. Research Institutes
8.3.4. Other End Users
9. North America Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
9.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
9.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
9.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
9.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
9.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
9.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
9.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
9.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
9.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
9.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
10. UK and European Union Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
10.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
10.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
10.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
10.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
10.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
10.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
10.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
10.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
10.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
10.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
10.6.1.4.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
10.6.1.4.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
10.6.1.5. France
10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
10.6.1.5.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
10.6.1.5.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
10.6.1.6.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
10.6.1.6.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
11. Asia Pacific Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
11.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
11.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
11.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
11.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
11.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
11.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
11.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
11.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
11.6.1.3. India
11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
11.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
11.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
11.6.1.4.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
11.6.1.4.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
11.6.1.5.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
11.6.1.5.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
11.6.1.6.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
11.6.1.6.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
12. Latin America Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
12.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
12.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
12.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
12.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
12.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
12.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
12.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
12.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
12.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
12.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
13. Middle East and Africa Point of Care Molecular Diagnostics Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
13.3. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
13.4. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
13.5. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
13.6.Point of Care Molecular Diagnostics Market: By Region, 2021-2031, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
13.6.1.1.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
13.6.1.1.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
13.6.1.2.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
13.6.1.2.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Product & Service, 2021-2031, USD (Million)
13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Technology, 2021-2031, USD (Million)
13.6.1.3.1. Point of Care Molecular Diagnostics Market: By Application, 2021-2031, USD (Million)
13.6.1.3.1. Point of Care Molecular Diagnostics Market: By End User, 2021-2031, USD (Million)
14. Company Profile
14.1. Abbott Laboratories (U.S.)
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. F. Hoffmann-La Roche Ltd. (Switzerland)
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. bioMerieux S.A. (France)
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Danaher Corporation (U.S.)
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Quidel Corporation (U.S.)
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. QIAGEN N.V. (Netherlands)
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Co-Diagnostics, Inc.
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Biocartis NV (Belgium)
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Meridian Bioscience, Inc. (U.S.)
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Thermo Fisher Scientific, Inc. (U.S.)
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Others
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
List of Figures
Figure 1 Global Point of Care Molecular Diagnostics Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Point of Care Molecular Diagnostics Market: Quality Assurance
Figure 5 Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022
Figure 6 Global Point of Care Molecular Diagnostics Market, By Technology, 2022
Figure 7 Global Point of Care Molecular Diagnostics Market, By Application, 2022
Figure 8 Global Point of Care Molecular Diagnostics Market, By End User, 2022
Figure 9 Global Point of Care Molecular Diagnostics Market, By Geography, 2022
Figure 10 Market Geographical Opportunity Matrix - Global Point of Care Molecular Diagnostics Market, 2022
Figure 11 Market Positioning of Key Point of Care Molecular Diagnostics Market Players, 2022
Figure 12 Global Point of Care Molecular Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 13 Global Point of Care Molecular Diagnostics Market, By Product & Service, 2022 Vs 2031, %
Figure 14 Global Point of Care Molecular Diagnostics Market, By Technology, 2022 Vs 2031, %
Figure 15 Global Point of Care Molecular Diagnostics Market, By Application, 2022 Vs 2031, %
Figure 16 Global Point of Care Molecular Diagnostics Market, By End User, 2022 Vs 2031, %
Figure 17 U.S. Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 18 Canada Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 19 Rest of North America Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 20 UK Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 21 Germany Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 22 Spain Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 23 Italy Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 24 France Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 25 Rest of Europe Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 26 China Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 27 Japan Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 28 India Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 29 Australia Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 30 South Korea Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 31 Rest of Asia Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 32 Brazil Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 33 Mexico Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 34 Rest of Latin America Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 35 GCC Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 36 Africa Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
Figure 37 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 12 Global Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 13 Global Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 14 Global Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 15 North America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 16 North America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 17 North America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 18 North America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 19 U.S. Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 110 U.S. Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 111 U.S. Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 112 U.S. Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 113 Canada Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 114 Canada Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 115 Canada Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 116 Canada Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 117 Rest of North America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 118 Rest of North America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 119 Rest of North America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 120 Rest of North America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 121 UK and European Union Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 122 UK and European Union Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 123 UK and European Union Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 124 UK and European Union Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 125 UK Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 126 UK Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 127 UK Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 128 UK Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 129 Germany Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 130 Germany Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 131 Germany Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 132 Germany Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 133 Spain Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 134 Spain Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 135 Spain Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 136 Spain Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 137 Italy Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 138 Italy Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 139 Italy Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 140 Italy Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 141 France Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 142 France Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 143 France Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 144 France Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 145 Rest of Europe Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 146 Rest of Europe Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 147 Rest of Europe Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 148 Rest of Europe Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 149 Asia Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 150 Asia Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 151 Asia Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 152 Asia Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 153 China Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 154 China Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 155 China Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 156 China Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 157 Japan Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 158 Japan Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 159 Japan Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 160 Japan Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 161 India Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 162 India Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 163 India Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 164 India Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 165 Australia Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 166 Australia Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 167 Australia Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 168 Australia Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 169 South Korea Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 170 South Korea Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 171 South Korea Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 172 South Korea Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 173 Latin America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 174 Latin America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 175 Latin America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 176 Latin America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 177 Brazil Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 178 Brazil Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 179 Brazil Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 180 Brazil Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 181 Mexico Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 182 Mexico Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 183 Mexico Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 184 Mexico Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 185 Rest of Latin America Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 186 Rest of Latin America Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 187 Rest of Latin America Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 188 Rest of Latin America Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 189 Middle East and Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 190 Middle East and Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 191 Middle East and Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 192 Middle East and Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 193 GCC Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 194 GCC Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 195 GCC Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 196 GCC Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 197 Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 198 Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 199 Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 1100 Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Table 1101 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Product & Service, 2021-2031, USD (Million)
Table 1102 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Technology, 2021-2031, USD (Million)
Table 1103 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By Application, 2021-2031, USD (Million)
Table 1104 Rest of Middle East and Africa Point of Care Molecular Diagnostics Market By End User, 2021-2031, USD (Million)
Companies Mentioned
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- bioMerieux S.A.
- Danaher Corporation
- Quidel Corporation
- QIAGEN N.V.
- Co-Diagnostics Inc.
- Biocartis NV
- Meridian Bioscience Inc
- Thermo Fisher Scientific Inc.
